Patents by Inventor Allan Rilling

Allan Rilling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apparatus and methods for on-line monitoring of fluorinated material in headspace of vial
    Patent number: 6943692
    Abstract: Apparatus and methods for monitoring the presence of an analyte in a closed vial wherein a sample contained within the closed vial is conveyed to an analyzer. The analyzer determines a value of a spectral property dependent on analyte concentration at a position within a headspace formed above the sample within the vial. An indicator is used to compare the measured value of the spectral property with a predetermined limit criteria to determine the presence or absence of the analyte. Vials wherein the presence of the analyte is detected are indicated as product vials whereas vials wherein the absence of the analyte is detected are indicated as rejected vials. The rejected vials are conveyed by a transferrer to a rejected vial station. A first portion of the product vials are conveyed by a sampler to a sample collection station. A second portion of the product vials are conveyed to a labeler.
    Type: Grant
    Filed: February 1, 2002
    Date of Patent: September 13, 2005
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: James Castner, Luc Boudreau, Allan Rilling
  • Apparatus and methods for on-line monitoring of fluorinated material in headspace of vial
    Publication number: 20030087445
    Abstract: Apparatus and methods for monitoring the presence of an analyte in a closed vial wherein a sample contained within the closed vial is conveyed to an analyzer. The analyzer determines a value of a spectral property dependent on analyte concentration at a position within a headspace formed above the sample within the vial. An indicator is used to compare the measured value of the spectral property with a predetermined limit criteria to determine the presence or absence of the analyte. Vials wherein the presence of the analyte is detected are indicated as product vials whereas vials wherein the absence of the analyte is detected are indicated as rejected vials. The rejected vials are conveyed by a transferrer to a rejected vial station. A first portion of the product vials are conveyed by a sampler to a sample collection station. A second portion of the product vials are conveyed to a labeler.
    Type: Application
    Filed: February 1, 2002
    Publication date: May 8, 2003
    Inventors: James F. Castner, Luc Boudreau, Allan Rilling